Rejection, Transplant Completed Phase 2 Trials for Antithymocyte immunoglobulin (rabbit) (DB00098)

Also known as: Transplant Rejection / Transplant rejections / Graft Rejection

IndicationStatusPhase
DBCOND0030946 (Rejection, Transplant)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00089947A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant RejectionTreatment
NCT00771875Randomized Trial for Mixed Acute RejectionTreatment
NCT00117689Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant RejectionPrevention